Clinical Trial Results:
A Multicentre, Open Label, Follow on Study to Assess the Maintenance of Effect, Tolerance and Safety of Sativex in the Treatment of Subjects with Neuropathic Pain. This will be followed by a randomised withdrawal phase (Part B) for a subset of patients.
Summary
|
|
EudraCT number |
2004-004395-36 |
Trial protocol |
GB CZ BE |
Global completion date |
29 Jul 2007
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
24 Oct 2018
|
First version publication date |
24 Oct 2018
|
Other versions |
|
Summary report(s) |
GWCL0404 EudraCT historical synopsis posting |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.